The G2 checkpoint is maintained by redundant pathways

Molecular and Cellular Biology

Volumn 19, Issue 9, 1999, Pages 5872-5881

  Passalaris, Tina M ^a   Benanti, Jennifer A ^a,b   Gewin, Lindy ^a,b   Kiyono, Tohru ^a,c   Galloway, Denise A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DOXORUBICIN; PHOSPHOTRANSFERASE; PROTEIN P53;

ANEUPLOIDY; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME ANALYSIS; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSCRIPTION REGULATION; WART VIRUS;

EID: 0032803877     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.9.5872     Document Type: Article

References (62)

1. Agarwal, M. L., A. Agarwal, W. R. Taylor, and G. R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92:8493-8497.
2. 1a. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology, vol. 2, p. 21.1.1-21.1.5. John Wiley & Sons, Inc., New York, N.Y.
3. Azzam, E. I., S. M. de Toledo, M. J. Pykett, H. Nagasawa, and J. B. Little. 1997. CDC2 is down-regulated by ionizing radiation in a p53-dependent manner. Cell Growth Differ. 8:1161-1169.
4. Barth, H., I. Hoffmann, S. Klein, M. Kaszkin, J. Richards, and V. Kinzel. 1996. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester. J. Cell. Physiol. 168:589-599.
5. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
6. Bunz, F., A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J. P. Brown, J. M. Sedivy, K. W. Kinzler, and B. Vogelstein. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
7. Cayrol, C., M. Knibiehler, and B. Ducommun. 1998. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16:311-320.
8. Datta, R., R. Hass, H. Gunji, R. Weichselbaum, and D. Kufe. 1992. Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Differ. 3:637-644.
9. Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
10. de Toledo, S. M., E. I. Azzam, P. Keng, S. Laffrenier, and J. B. Little. 1998. Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21 Waf1. Cell Growth Differ. 9:887-896.
11. Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
12. 2/M-phase transition. Mol. Cell. Biol. 18:546-557.
13. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
14. Enoch, T., and C. Norbury. 1995. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20:426-430. (Review.)
15. Evans, T., E. T. Rosenthal, J. Youngblom, D. Distel, and T. Hunt. 1983. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33:389-396.
16. cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol. Cell. Biol. 11:1965-1971.
17. Foster, S. A., G. W. Demers, B. G. Etscheid, and D. A. Galloway. 1994. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:5698-5705.
18. Furnari, B., N. Rhind, and P. Russell. 1997. CDC25 mitotic inducer targeted by CHK1 DNA damage checkpoint kinase. Science 277:1495-1497.
19. Gould, K. L., and P. Nurse. 1989. Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 342:39-45.
20. Greenblatt, M. S., W. P. Bennett, M. Hollstein, and C. C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-4878. (Review.)
21. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
22. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
23. Hawkins, D. S., G. W. Demers, and D. A. Galloway. 1996. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res. 56: 892-898.
24. Hermeking, H., C. Lengauer, K. Polyak, T. He, L. Zhang, S. Thiagalingam, K. Kinzler, W., and B. Vogelstein. 1998. 14-3-3 is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1:3-11.
25. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53. (Review.)
26. Innocente, S. A., J. L. Abrahamson, J. P. Cogswell, and J. M. Lee. 1999. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA 94:2147-2152.
27. Jin, P., Y. Gu, and D. O. Morgan. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134:963-970.
28. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
29. Kaufmann, W. K., J. L. Schwartz, J. C. Hurt, L. L. Byrd, D. A. Galloway, E. Levedakou, and R. S. Paules. 1997. Inactivation of G(2) checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6. Cell Growth Differ. 8:1105-1114.
30. Kiyono, T., A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:11612-11616.
31. Kiyono, T., A. Hiraiwa, S. Ishii, T. Takahashi, and M. Ishibashi. 1994. Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin. J. Virol. 68:4656-4661.
32. Kley, N., R. Y. Chung, S. Fay, J. P. Loeffler, and B. R. Seizinger. 1992. Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res. 20:4083-4087.
33. Lane, D. P. 1992. Cancer. p53, guardian of the genome. Nature 358:15-16. (News; comment.)
34. Lee, T. H., M. J. Solomon, M. C. Mumby, and M. W. Kirschner. 1991. INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell 64:415-423.
35. Leffers, H., P. Madsen, H. H. Rasmussen, B. Honore, A. H. Andersen, E. Walbum, J. Vandekerckhove, and J. E. Cells. 1993. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J. Mol. Biol. 231:982-998.
36. Linke, S. P., K. C. Clarkin, and G. M. Wahl. 1997. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res. 57:1171-1179.
37. Liu, F., J. J. Stanton, Z. Wu, and H. Plwnica-Worms. 1997. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17:571-583.
38. Lu, K. P., and T. Hunter. 1995. Evidence for a NIMA-like mitotic pathway in vertebrate cells. Cell 81:413-424.
39. Maity, A., W. G. McKenna, and R. J. Muschel. 1995. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J. 14:603-609.
40. McGowan, C. H., and P. Russell. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J. 12:75-85.
41. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
42. Muschel, R. J., H. B. Zhang, G. Iliakis, and W. G. McKenna. 1991. Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res. 51:5113-5117.
43. Muschel, R. J., H. B. Zhang, and W. G. McKenna. 1993. Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells. Cancer Res. 53:1128-1135.
44. O'Connor, P. M. 1997. Mammalian G1 and G2 phase checkpoints. Cancer Surv. 29:151-182. (Review.)
45. O'Connor, P. M., D. K. Ferris, I. Hoffmann, J. Jackman, G. Draetta, and K. W. Kohn. 1994. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc. Natl. Acad. Sci. USA 91:9480-9484.
46. O'Connor, P. M., D. K. Ferris, G. A. White, J. Pines, T. Hunter, D. L. Longo, and K. W. Kohn. 1992. Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ. 3:43-52.
47. Osmani, A. H., S. L. McGuire, and S. A. Osmani. 1991. Parallel activation of the NIMA and p34cdc2 cell cycle-regulated protein kinases is required to initiate mitosis in A. nidulans. Cell 67:283-291.
48. Parker, L. L., and H. Piwnica-Worms. 1992. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257:1955-1957.
49. Peng, C. Y., P. R. Graves, R. S. Thoma, Z. Q. Wu, A. S. Shaw, and H. Piwnica-Worms. 1997. Mitotic and G(2) checkpoint control-regulation of 14-3-3 protein binding by phosphorylation of CDC25C on serine-216. Science 277:1501-1505.
50. Prasad, G. L., E. M. Valverius, E. McDuffie, and H. L. Cooper. 1992. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 3:507-513.
51. Rhind, N., B. Furnari, and P. Russell. 1997. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev. 11:504-511.
52. Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, R. Q. Wu, H. Piwnica-Worms, and S. J. Elledge. 1997. Conseration of the CHK1 checkpoint pathway in mammals - linkage of DNA damage to CDK regulation through CDC25. Science 277:1497-1501.
53. Sandell, L. L., and V. A. Zaklan. 1993. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 75:729-739.
54. Schultz, S. J., A. M. Fry, C. Sutterlin, T. Ried, and E. A. Nigg. 1994. Cell cycle-dependent expression of Nek2, a novel human protein kinase related to the NIMA mitotic regulator of Aspergillus nidulans. Cell Growth Differ. 5:625-635.
55. Smythe, C., and J. W. Newport. 1992. Coupling of mitosis to the completion of S phase in Xenopus occurs via modulation of the tyrosine kinase that phosphorylates p34cdc2. Cell 68:787-797.
56. Stein, G. H., L. F. Drullinger, R. S. Robetorye, O. M. Pereira-Smith, and J. R. Smith. 1991. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc. Natl. Acad. Sci. USA 88:11012-11016.
57. Stewart, N., G. G. Hicks, F. Paraskevas, and M. Mowat. 1995. Evidence for a second cell cycle block at G2/M by p53. Oncogene 10:109-115.
58. Sugrue, M. M., D. Y. Shin, S. W. Lee, and S. A. Aaronson. 1997. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA 94:9648-9653.
59. Vikhanskaya, F., E. Erba, M. D'Incalci, and M. Broggini. 1994. Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucleic Acids Res. 22:1012-1017.
60. Walworth, N., S. Davey, and D. Beach. 1993. Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363:368-371.
61. Weinert, T. 1997. A DNA damage checkpoint meets the cell cycle engine. Science 277:1450-1451. (Comment.)
62. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.